Experts believe vaccinating children is key to achieving herd immunity

Be the First to Comment Read

Experts believe vaccinating children is key to achieving herd immunity

 Experts believe vaccinating children is key to achieving herd immunity

Source: siam.pukkato, Shutterstock

Summary

  • With the world getting millions of COVID-19 vaccines daily, experts believe that herd immunity can only be achieved if children start getting vaccinated.
  • Vaccine developers are conducting pediatric clinical trials to confirm the efficacy of the vaccines in children.
  • Recently, Pfizer joined the race and started clinical trials in children as young as six months.

Even as vaccines reach millions of people daily worldwide, experts view vaccination in children as a critical step in ensuring that we achieve herd immunity to defeat the pandemic.

The CDC highlighted that getting children vaccinated is vital to reach herd immunity and protecting the world against the virus. Although fewer kids, compared to adults, have been infected by SARS-CoV-2, they can still become sick and spread the coronavirus, CDC emphasised.

Apart from children’s health risks, there are concerns about how easily they can spread the virus.

Child Vaccinations for Herd Immunity

Herd immunity occurs when a larger population becomes immune to a virus through vaccination, and the virus has no one to infect.

Director of the National Institute of Allergy and Infectious Diseases, Mr Anthony Fauci, stated that we cannot reach herd immunity until children are vaccinated.

Source: © Iqoncept | Megapixl.com

Mr Fauci added-

Some media reports mention that Dr Fauci has estimated 70-85% of the population would need to be vaccinated or become immune to achieve herd immunity.

Must Read: Could Herd Immunity Help in Preventing COVID-19?

Pediatric clinical trials of COVID-19 vaccine

Vaccine developers have started clinical trials on adolescents as well as younger children to evaluate the safety and efficacy of COVID-19 vaccines for each age.

© Spukkato | Megapixl.com

  • In the US, recently, Pfizer-BioNTech joined Moderna to conduct pediatric clinical trials of their COVID-19 vaccines.
  • Johnson & Johnson (NYSE:JNJ) is planning to commence its pediatric studies.
  • Last month in the UK, AstraZeneca started a clinical trial for its COVID-19 vaccine among 6–17-year-old children.
  • In China, Sinovac announced that the Company had submitted initial data to Chinese medical regulators demonstrating its vaccine is safe in children and adolescents.

Moreover, Pfizer Inc (NYSE:PFE) and Moderna Inc (NYSE:MRNA) anticipate releasing their findings shortly for how the two shots of their vaccines performed in the 12 and older children.

ALSO READ: EU could block vaccine export amid a shortage of AstraZeneca’s COVID-19 shots

Pfizer-BioNTech pediatric study will test their vaccine in children as young as six months old. The Company updated that the first young children in the vaccine’s pediatric trial have got their initial shots.

Pfizer study aims to examine how the vaccine jabs should be given to young children, who are not considered the most vulnerable to COVID-19 but can be infected and spread the virus.

DO READ: 3 Stocks to evaluate to beat pandemic woes

Disclaimer

Speak your Mind

Featured Articles

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK